How much funding has CellChorus raised?

CellChorus has raised $3.8M in total funding, most recently a Grant round.

Who are CellChorus's investors?

CellChorus's investors include National Center for Advancing Translational Sciences (NCATS), National Science Foundation, National Institute of General Medical Sciences (NIGMS), Y Combinator Continuity Fund, National Institutes of Health.

When was CellChorus founded?

CellChorus was founded in 2020.

Where is CellChorus headquartered?

CellChorus is headquartered in Houston, Texas, United States.

What industry is CellChorus in?

CellChorus operates in Drug Discovery, Healthcare, Artificial Intelligence.

CellChorus

The dynamic single-cell analysis company

Houston, United States · Founded 2020 · $3.8M raised

Drug Discovery

Healthcare

Artificial Intelligence

YC S21

Headquarters: Houston, Texas
Employees: 1–10
Founded: 2020
Website: cellchorus.com

Total Funding: $3.8M
Last Round: $350K GrantOct 2024
Rounds: 6

About

At CellChorus, we apply artificial intelligence to evaluate thousands of microscopy videos in parallel to evaluate how immune cells move, interact and perform over time. This allows our customers to discover, develop, manufacture and deliver cell therapies, antibodies, vaccines and other novel therapies faster, at lower expense, and with higher rates of success. Our customers include top-25 biopharma companies and seed-stage biotechs that are developing cell therapies, antibody therapeutics and vaccines (including one of the few companies with an approved CAR T cell therapy). Hear from the team at https://www.youtube.com/watch?v=IE9x_tm0XnI

Summary

CellChorus is a Drug Discovery company based in Houston, United States, founded in 2020. It has raised $3.8M in total across 6 rounds, most recently a $350K Grant round in Oct 2024. Investors include National Center for Advancing Translational Sciences (NCATS), National Science Foundation and National Institute of General Medical Sciences (NIGMS).